These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 16857251)

  • 21. Effects of LY379268, a selective group II metabotropic glutamate receptor agonist on EEG activity, cortical perfusion, tissue damage, and cortical glutamate, glucose, and lactate levels in brain-injured rats.
    Stover JF; Sakowitz OW; Beyer TF; Dohse NK; Kroppenstedt SN; Thomale UW; Schaser KD; Unterberg AW
    J Neurotrauma; 2003 Apr; 20(4):315-26. PubMed ID: 12866811
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The metabotropic glutamate 2/3 receptor agonists LY354740 and LY379268 selectively attenuate phencyclidine versus d-amphetamine motor behaviors in rats.
    Cartmell J; Monn JA; Schoepp DD
    J Pharmacol Exp Ther; 1999 Oct; 291(1):161-70. PubMed ID: 10490900
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of group II metabotropic glutamate receptor modulation on ethanol- and sucrose-seeking and consumption in the rat.
    Windisch KA; Czachowski CL
    Alcohol; 2018 Feb; 66():77-85. PubMed ID: 29220747
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selective action of (-)-2-oxa-4-aminobicyclo[3.1.0]hexane-4,6-dicarboxylate (LY379268), a group II metabotropic glutamate receptor agonist, on basal and phencyclidine-induced dopamine release in the nucleus accumbens shell.
    Greenslade RG; Mitchell SN
    Neuropharmacology; 2004 Jul; 47(1):1-8. PubMed ID: 15165829
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Investigating the role of mGluR2 versus mGluR3 in antipsychotic-like effects, sleep-wake architecture and network oscillatory activity using novel Han Wistar rats lacking mGluR2 expression.
    Wood CM; Wafford KA; McCarthy AP; Hewes N; Shanks E; Lodge D; Robinson ESJ
    Neuropharmacology; 2018 Sep; 140():246-259. PubMed ID: 30005976
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The metabotropic glutamate 2/3 receptor agonist LY379268 induces anxiety-like behavior at the highest dose tested in two rat models of anxiety.
    Grivas V; Markou A; Pitsikas N
    Eur J Pharmacol; 2013 Sep; 715(1-3):105-10. PubMed ID: 23769742
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The glutamatergic compounds sarcosine and N-acetylcysteine ameliorate prepulse inhibition deficits in metabotropic glutamate 5 receptor knockout mice.
    Chen HH; Stoker A; Markou A
    Psychopharmacology (Berl); 2010 May; 209(4):343-50. PubMed ID: 20217053
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The mGluR2/3 agonist LY379268 blocks the effects of GLT-1 upregulation on prepulse inhibition of the startle reflex in adult rats.
    Bellesi M; Conti F
    Neuropsychopharmacology; 2010 May; 35(6):1253-60. PubMed ID: 20072121
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Environmental enrichment and a selective metabotropic glutamate receptor
    Garcia EJ; Cain ME
    Pharmacol Biochem Behav; 2020 May; 192():172907. PubMed ID: 32179027
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alcohol-induced neurodegeneration, suppression of transforming growth factor-beta, and cognitive impairment in rats: prevention by group II metabotropic glutamate receptor activation.
    Cippitelli A; Damadzic R; Frankola K; Goldstein A; Thorsell A; Singley E; Eskay RL; Heilig M
    Biol Psychiatry; 2010 May; 67(9):823-30. PubMed ID: 20132926
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analgesic effects of the selective group II (mGlu2/3) metabotropic glutamate receptor agonists LY379268 and LY389795 in persistent and inflammatory pain models after acute and repeated dosing.
    Jones CK; Eberle EL; Peters SC; Monn JA; Shannon HE
    Neuropharmacology; 2005; 49 Suppl 1():206-18. PubMed ID: 15998527
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Awake rat pharmacological magnetic resonance imaging as a translational pharmacodynamic biomarker: metabotropic glutamate 2/3 agonist modulation of ketamine-induced blood oxygenation level dependence signals.
    Chin CL; Upadhyay J; Marek GJ; Baker SJ; Zhang M; Mezler M; Fox GB; Day M
    J Pharmacol Exp Ther; 2011 Mar; 336(3):709-15. PubMed ID: 21172908
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Subchronic administration of LY354740 does not modify ketamine-evoked behavior and neuronal activity in rats.
    Imre G; Fokkema DS; Ter Horst GJ
    Eur J Pharmacol; 2006 Aug; 544(1-3):77-81. PubMed ID: 16860791
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The mGluR2/3 agonist LY379268 attenuates context- and discrete cue-induced reinstatement of sucrose seeking but not sucrose self-administration in rats.
    Bossert JM; Poles GC; Sheffler-Collins SI; Ghitza UE
    Behav Brain Res; 2006 Oct; 173(1):148-52. PubMed ID: 16834996
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute administration of typical and atypical antipsychotics reduces EEG γ power, but only the preclinical compound LY379268 reduces the ketamine-induced rise in γ power.
    Jones NC; Reddy M; Anderson P; Salzberg MR; O'Brien TJ; Pinault D
    Int J Neuropsychopharmacol; 2012 Jun; 15(5):657-68. PubMed ID: 21733235
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The mGluR
    Sokolenko E; Hudson MR; Nithianantharajah J; Jones NC
    J Psychopharmacol; 2019 Dec; 33(12):1588-1599. PubMed ID: 31580222
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the effects of diazepam, the CRF1 antagonist CP-154,526 and the group II mGlu receptor agonist LY379268 on stress-evoked extracellular norepinephrine levels.
    Lorrain DS; Baccei CS; Correa LD; Bristow LJ
    Neuropharmacology; 2005 Jun; 48(7):927-35. PubMed ID: 15857619
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DOI-induced deficits in prepulse inhibition in Wistar rats are reversed by mGlu2/3 receptor stimulation.
    Wischhof L; Aho HE; Koch M
    Pharmacol Biochem Behav; 2012 Jul; 102(1):6-12. PubMed ID: 22469865
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The group 2 metabotropic glutamate receptor agonist LY379268 rescues neuronal, neurochemical and motor abnormalities in R6/2 Huntington's disease mice.
    Reiner A; Lafferty DC; Wang HB; Del Mar N; Deng YP
    Neurobiol Dis; 2012 Jul; 47(1):75-91. PubMed ID: 22472187
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reversal of evoked gamma oscillation deficits is predictive of antipsychotic activity with a unique profile for clozapine.
    Hudson MR; Rind G; O'Brien TJ; Jones NC
    Transl Psychiatry; 2016 Apr; 6(4):e784. PubMed ID: 27093066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.